Merck & Co., Inc. (MRK) Cash flow statement
Top 11 of 24 line items reported by MRK · 250+ in the full API →
Merck & Co., Inc. (MRK) · Cash Flow Statement
Consolidated Statements of Cash Flows
Annual · In millions USD, except per-share data · Latest filed Feb 24, 2026 · FY ends Dec 31
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Net Cash Flow from Operating Activities | $16,472 | $21,468 | $13,006 | $19,095 | |
| Net Income | 18,254 | 17,117 | 365 | 14,519 | |
| Net Cash Flow from Investing Activities | $(13,741) | $(7,734) | $(14,083) | $(4,960) | |
| Capital Expenditures | -4,112 | -3,372 | -3,863 | -4,388 | |
| Other Investing Activities | -58 | -127 | -36 | -89 | |
| Net Cash Flow from Financing Activities | $(1,922) | $(7,032) | $(4,810) | $(9,119) | |
| Common stock repurchased | -5,084 | -1,306 | -1,346 | 0 | |
| Dividends Paid | -8,176 | -7,840 | -7,445 | -7,012 | |
| Other financing activities | (131) | (372) | (328) | (240) | |
| Net Cash Flow | $1,372 | $6,409 | $(5,864) | $4,606 | |
| Free Cash Flow | 12,360 | 18,096 | 9,143 | 14,707 | |
13 more line items available via the API
Depreciation & AmortizationStock-Based CompensationAccounts receivableInventoriesIncome taxes payablePurchases of investmentsNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid